TR35 Judges — 2002
DAVID BALTIMORE
President, California Institute of Technology;
Nobel laureate,medicine
ALFRED BERKELEY
Vice chairman,
NASDAQ
SABEER BHATIA
Cofounder,
Hotmail;
TR100 finalist, 1999
RICHARD DEMILLO
Vice president and chief technology officer,
Hewlett-Packard
R. JOHN HANSMAN
Professor of aeronautics and astronautics,
MIT
UNNA HUH
Member, National Assembly,
Republic of Korea
JOSEPH JACOBSON
Associate professor,
MIT Media Laboratory;
TR100 finalist, 1999
PHILIPPE JANSON
Member,
IBM Academy of Technology
NATALIE JEREMIJENKO
Director, Experimental Product Design Lab,
Yale University;
TR100 finalist, 1999
CHRISTINE KARMAN
Founder,
Tryllian, the Netherlands
ROBERT LANGER
Professor of chemical and biomedical engineering, MIT;
Professor, Harvard-MIT Division of Health Science and Technology
RICHARD K. LESTER
Director, Industrial Performance Center, and professor of nuclear engineering,
MIT
ROBERT M. METCALFE
General partner, Polaris Venture Partners;
Inventor, Ethernet;
Founder, 3Com
JUZAR MOTIWALLA
Partner,
Green Dot Capital,
Republic of Singapore
CHERRY A. MURRAY
Senior vice president, research strategy, wireless physical science research, Bell Labs,
Lucent Technologies
NICHOLAS NEGROPONTE
Professor of media technology, MIT;
Chairman, MIT Media Laboratory
KIM POLESE
Chairman,
Marimba
JUDITH RODIN
President,
University of Pennsylvania
DARI SHALON
Partner,
Shalon Ventures, Israel;
TR100 finalist, 1999
PHILLIP SHARP
Institute Professor and director of the McGovern Institute for Brain Research,
MIT;
Nobel laureate, medicine
ALAN SPOON
Managing general partner,
Polaris Venture Partners
ANTHONY SUN
Managing general partner,
Venrock Associates
LARRY WEBER
Founder,Weber Shandwick Worldwide;
Chairman and CEO, Interpublic’s Advanced Marketing Services
ANN WINBLAD
Cofounding partner,
Hummer Winblad Venture Partners
Keep Reading
Most Popular
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected
Illustration by Rose WongGet the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.